Informazione:
Errore:
ID
34327
Descrizione
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01170962
collegamento
https://clinicaltrials.gov/show/NCT01170962
Keywords
versioni (1)
- 16/01/19 16/01/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
16 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Hepatitis C Virus NCT01170962
Eligibility Hepatitis C Virus NCT01170962
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Virus NCT01170962
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
subjects chronically infected with hcv genotype 1
boolean
ID.2
Item
non-responder to prior therapy with peginterferon alfa and ribavirin
boolean
ID.3
Item
hcv rna viral load of ≥ 100,00 iu/ml
boolean
ID.4
Item
results of a liver biopsy ≤ 24 months prior to randomization consistent with chronic hcv infection; for compensated cirrhotics can be any time prior to randomization (compensated cirrhotics will be capped at 10% of randomized study population)
boolean
ID.5
Item
ultrasound, ct scan or mri results 12 months prior to randomization that do not demonstrate hepatocellular carcinoma
boolean
ID.6
Item
body mass index (bmi) of 18 to 35 kg/m2
boolean
ID.7
Item
positive for hepatitis b infection (hbsag) or hiv-1/hiv-2 antibody at screening
boolean
ID.8
Item
evidence of medical condition associated with chronic liver disease other than hcv
boolean
ID.9
Item
evidence of decompensated cirrhosis based on radiologic criteria or biopsy
boolean